Cushing's disease

Stop sign

Biotech

FDA rejects Sanofi MS drug, Corcept Cushing's syndrome therapy

The festive period brought some unwanted post for both Sanofi and Corcept Therapeutics in the form of FDA rejections.

James Waldron Jan 2, 2026 7:10am